Run drug discovery and materials research directly from AI
Computational infrastructure for drug discovery and materials science.
Drug discovery doesn't take 12 years because of science. It takes 12 years because of infrastructure. NovoMCP removes the waiting.
Drug Discovery
From target identification to patient stratification. 122 million pre-computed compounds, GPU docking, molecular dynamics, and clinical outcome prediction - nine autonomous stages, one platform.
Explore Drug Discovery →Materials Science
OLED emission screening, electrolyte voltage stability, reaction feasibility, activation barriers, inorganic discovery. Every element in the periodic table. Same endpoint.
Explore Materials Science →Latest
Server-side tool search for a 62-tool MCP platform
What happens when the AI vendor's fix doesn't reach you
NovoMCP reaches 62 tools
Materials science, clinical prediction, and metalloprotein parameterization join the platform.
Introducing the Scale tier
No seats. No per-user fees. 15,000 credits per month with warehouse connectors.
The bottleneck is never the science. It's the infrastructure between the science.
Every handoff between tools, every compliance check deferred to the end, every week waiting for compute access is time that compounds into years.
NovoMCP pre-computes the knowable, automates the routine, and keeps the researcher at the center of every decision that matters. The platform checks in when judgment is needed. The rest runs.